Human MARCH1, 2, and 8 block Ebola virus envelope glycoprotein cleavage via targeting furin P domain

J Med Virol. 2024 Feb;96(2):e29445. doi: 10.1002/jmv.29445.

Abstract

Membrane-associated RING-CH (MARCH) family proteins were recently reported to inhibit viral replication through multiple modes. Previous work showed that human MARCH8 blocked Ebola virus (EBOV) glycoprotein (GP) maturation. Our study here demonstrates that human MARCH1 and MARCH2 share a similar pattern to MARCH8 in restricting EBOV GP-pseudotyped viral infection. Human MARCH1 and MARCH2 retain EBOV GP at the trans-Golgi network, reduce its cell surface display, and impair EBOV GP-pseudotyped virions infectivity. Furthermore, we uncover that the host proprotein convertase furin could interact with human MARCH1/2 and EBOV GP intracellularly. Importantly, the furin P domain is verified to be recognized by MARCH1/2/8, which is critical for their blocking activities. Besides, bovine MARCH2 and murine MARCH1 also impair EBOV GP proteolytic processing. Altogether, our findings confirm that MARCH1/2 proteins of different mammalian origins showed a relatively conserved feature in blocking EBOV GP cleavage, which could provide clues for subsequent MARCHs antiviral studies and may facilitate the development of novel strategies to antagonize enveloped virus infection.

Keywords: Ebola virus; MARCH; cleavage; envelope glycoprotein; furin.

MeSH terms

  • Animals
  • Cattle
  • Cell Line
  • Ebolavirus*
  • Furin / metabolism
  • Glycoproteins
  • Hemorrhagic Fever, Ebola*
  • Humans
  • Mammals / metabolism
  • Membrane Proteins / metabolism
  • Mice
  • Ubiquitin-Protein Ligases / metabolism
  • Viral Envelope / metabolism
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / metabolism

Substances

  • Furin
  • Glycoproteins
  • MARCH1 protein, mouse
  • Membrane Proteins
  • Ubiquitin-Protein Ligases
  • Viral Envelope Proteins
  • MARCHF2 protein, human
  • MARCHF8 protein, human